February 26, 2015 8:20 PM ET

Biotechnology

Company Overview of Akebia Therapeutics, Inc.

Company Overview

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is AKB-6548, a HIF-PH inhibitor, which is in Phase IIb clinical trials for patients with anemia secondary to chronic kidney disease who are not dependent on dialysis. The company is also developing a development program for patients dependent on dialysis. Akebia Therapeutics, Inc. was founded in 2007 and is headquartered in Cambridge, Massachusetts.

245 First Street

Suite 1100

Cambridge, MA 02142

United States

Founded in 2007

24 Employees

Phone:

617-871-2098

Key Executives for Akebia Therapeutics, Inc.

Chief Executive Officer, President and Director
Age: 50
Total Annual Compensation: $162.0K
Compensation as of Fiscal Year 2013.

Akebia Therapeutics, Inc. Key Developments

Akebia Therapeutics, Inc.(NasdaqGM:AKBA) added to NASDAQ Biotechnology Index

Akebia Therapeutics, Inc. will be added to the NASDAQ Biotechnology Index.

Akebia Therapeutics, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-10-2015 02:00 PM

Akebia Therapeutics, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-10-2015 02:00 PM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: John P. Butler, Chief Executive Officer, President and Director.

Akebia Therapeutics, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 01:00 PM

Akebia Therapeutics, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 01:00 PM. Venue: The Crowne Plaza Hotel, New York, New York, United States. Speakers: John P. Butler, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
Antria, Inc. United States
The GID Group, Inc. United States
Diomics Corporation United States
Nextran, Inc. United States
Ixion Biotechnology, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Akebia Therapeutics, Inc., please visit www.akebia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.